---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000467"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2025-03-18T23:59:59+00:00"
generated_at: "2026-05-24T13:23:04.622554+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Lipella completes final close of Series B offering ($88.5K) and launches March warrant offering

## Summary
- Final close sold 885 shares of Series B preferred at $100/share for $88,500 gross; net proceeds $73,455.
- Warrant offering: up to 60,000 warrants at $0.125 each, each exercisable for 1 Series B share ($100) convertible at $2.16.
- Placement agent Spartan receives $15,045 fees, 10,326 Series C preferred shares, and warrants for 4,060 common shares.
- Registration rights require filing within 30 days; failure triggers 100,000 common shares or cash penalty monthly.
- Proceeds from both offerings intended for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001753926-25-000467
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2025-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000467/0001753926-25-000467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392625000467/g084733_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000467
- JSON: https://secwatch.observer/filing/0001753926-25-000467.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.